Drug Research
Drug Discovery & Development

Drug Discovery & Development News

View news from other Pharmaceutical sectors:
31-45 of 4547 results
New international consortium formed to speed up drug discovery in kidney diseases
By PBR Staff Writer
A new international consortium, including academic institutions such as the Universities of Bristol and Cambridge and drugmaker Evotec, has been established to enhance the discovery of drugs to treat kidney diseases.
Drug Research > Drug Discovery & Development > News
Spark Therapeutics, Pfizer amend license deal for investigational SPK-9001 in hemophilia B
Spark Therapeutics and Pfizer have entered into an amendment to their license agreement for SPK-9001, an investigational gene therapy for hemophilia B.
Drug Research > Drug Discovery & Development > News
Xenetic signs sublicense deal related to PolyXen technology with Baxalta
Xenetic Biosciences has entered into a Right to Sublicense Agreement with Baxalta, Baxalta, and Baxalta (collectively, with their affiliates, “Baxalta”), wholly-owned subsidiaries of Shire.
Drug Research > Drug Discovery & Development > News
Boehringer, Dicerna partner on RNAi treatment for NASH
By PBR Staff Writer
Boehringer Ingelheim and Dicerna Pharmaceuticals have partnered to develop treatments for chronic liver diseases including Nonalcoholic Steatohepatitis (NASH).
Drug Research > Drug Discovery & Development > News
Amgen to buy Japanese joint venture
By PBR Staff Writer
Amgen has entered an agreement to acquire Kirin-Amgen, its joint venture (JV) with Japan-based Kirin Holdings for $780m.
Drug Research > Drug Discovery & Development > News
Aviragen Therapeutics and Vaxart sign merger deal
By PBR Staff Writer
Aviragen Therapeutics, which is engaged in the discovery and development of direct-acting antivirals to treat infections with limited therapeutic options, has signed a merger agreement with Vaxart, a clinical-stage company focused on developing oral recombinant vaccines.
Drug Research > Drug Discovery & Development > News
Voyager to gain global rights to VY-AADC program for advanced Parkinson’s disease
Voyager Therapeutics, a clinical-stage gene therapy company focused on developing treatments for severe neurological diseases, has announced an update to its VY-AADC program for advanced Parkinson’s disease.
Drug Research > Drug Discovery & Development > News
Researchers identify new genetic variants for breast cancer risk
A major international collaboration involving hundreds of researchers worldwide has identified seventy-two new genetic variants that contribute to the risk of developing breast cancer.
Drug Research > Drug Discovery & Development > News
Incyte, MacroGenics sign licensing agreement for anti-PD-1 monoclonal antibody MGA012
Incyte and MacroGenics have entered into an exclusive global collaboration and license agreement for MacroGenics’ MGA012, an investigational monoclonal antibody that inhibits programmed cell death protein 1 (PD-1).
Drug Research > Drug Discovery & Development > News
AbbVie, Alector to develop novel treatments for Alzheimer's disease
By PBR Staff Writer
AbbVie has collaborated with Alector to develop and commercialize new treatments for Alzheimer's disease and other neurodegenerative disorders.
Drug Research > Drug Discovery & Development > News
Aurinia to expand voclosoprin renal franchise
Aurinia Pharmaceuticals revealed plans to expand its voclosoprin renal franchise to include focal segmental glomerulosclerosis (FSGS) and minimal change disease (MCD).
Drug Research > Drug Discovery & Development > News
Boehringer Ingelheim partners with TARGET to progress NASH research
TARGET PharmaSolutions announced that Boehringer Ingelheim International has entered into a multi-year strategic partnership for TARGET-NASH.
Drug Research > Drug Discovery & Development > News
Alnylam, Vir to jointly advance RNAi therapeutics for infectious diseases
Alnylam Pharmaceuticals has announced an exclusive licensing agreement with Vir Biotechnology for the development and commercialization of RNAi therapeutics for infectious diseases, including chronic hepatitis B virus (HBV) infection.
Drug Research > Drug Discovery & Development > News
Takeda, HemoShear collaborate to develop drugs for liver diseases
By PBR Staff Writer
Takeda has collaborated with HemoShear Therapeutics to discover and develop novel therapeutics for liver diseases such as nonalcoholic steatohepatitis (NASH).
Drug Research > Drug Discovery & Development > News
Moleculin to collaborate with University of Bergen for immune stimulation drug
Moleculin Biotech has entered into an agreement to collaborate with the University of Bergen to expand research on inhibition of brain metastasis by its pre-clinical drug WP1066 and its ability to increase immune system response to cancer and suppression of tumor cell proliferation and survival.
Drug Research > Drug Discovery & Development > News
31-45 of 4547 results